Safety and Efficacy of Ledipasvir/Sofosbuvir without on-Treatment Laboratory Monitoring in HCV-Infected Rwandans: The Shared 2 Study
Paul R. Grant(University College London Hospitals NHS Foundation Trust), Neera Gupta(Children's National), Jules Kabahizi, Fabienne Shumbusho, Cyprien Ntirenganya, Jean Damascène Makuza(University of British Columbia), Aimable Mbituyumuremyi, Jennifer Ilo Van Nuil, Sabin Nsanzimana(Rwanda Biomedical Center), Constance Mukabatsinda
Hepatology
January 1, 2018
Cited by 0
Related Papers
Rwanda 20 years on: investing in life
|The Lancet|2014|247
Risk Factors for Initial Surgery in Pediatric Patients With Crohn’s Disease
|Gastroenterology|2006|195
Presentation and Disease Course in Early- Compared to Later-Onset Pediatric Crohn's Disease
|The American Journal of Gastroenterology|2008|148